Overweight Clinical Trial
Official title:
The Effect of Physical Activity Intervention Flexibility on the Time Course of Changes in Body Composition and Metabolism
Verified date | October 2016 |
Source | University of Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
The investigators goal is to optimise physical activity interventions to help previously
inactive women improve their body shape and composition. Many people seeking to lose weight
or improve body composition initiate an exercise programme. The most common recommendation
of an exercise intervention for someone attempting to manage their weight, has been to
'prescribe' the recommended 150 minutes of exercise per week (World Health Organisation),
often using one mode of exercise. An alternative approach might be to offer a portfolio of
activities, from which the exerciser can pick and choose, to facilitate greater amounts of
physical activity. The problem with this is how do you account for the different intensities
of walking, washing the car, playing badminton, cycling, jogging, etc? In this study, the
investigators will try to overcome this barrier by allocating a number of "physical activity
points" to each activity. Using this physical activity points system, participants will be
provided with a points target that they can meet using any combination of activities.
The investigators research aim is therefore to compare this points-based system against the
traditional 5x30minute prescription (and sedentary control) for their ability to help
previously inactive women to drop a dress size, increase fat burning, positively change
their body composition and tone their tummy.
Status | Active, not recruiting |
Enrollment | 60 |
Est. completion date | December 2017 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 25 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Female - Aged 25-50 years old - Inactive (less than 150 minutes of moderate-intensity aerobic physical activity per week) - BMI 25-35 kg/m2 - Good general health, as assessed by the School of Sport, Exercise and Rehabilitation Sciences' General Health Questionnaire - Willing to strictly comply with all study procedures and restrictions - Willing to participate, as demonstrated by voluntary written informed consent Exclusion Criteria: - Positive result from the urine sample pregnancy test - Currently breast feeding - Currently participating in another clinical trial deemed to potentially interfere with this study - Current or recent (within the last 30 days) smoker - Currently taking prescription or non-prescription medication that may interfere with metabolism (including beta-blockers, insulin, bronchodilators, anti-inflammatory agents, thyroxine and medication/supplements that in the opinion of the investigators may affect metabolism). |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences | Birmingham |
Lead Sponsor | Collaborator |
---|---|
University of Birmingham | Cereal Partners Worldwide |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Blood-borne markers of metabolic health | 4 weeks, 12 weeks, 24 weeks | No | |
Other | Psychological measures relating to perceived body image | 4 weeks, 12 weeks, 24 weeks | No | |
Other | Psychological measures of attitudes towards exercise and physical activity | 4 weeks, 12 weeks, 24 weeks | No | |
Primary | Change in body composition (fat and fat-free mass in kg) | 4 weeks, 12 weeks and 24 weeks | No | |
Secondary | Perceived body shape | 4 weeks, 12 weeks and 24 weeks | No | |
Secondary | Maximal aerobic capacity | 4 weeks, 12 weeks, 24 weeks | No | |
Secondary | Fat oxidation rates | 4 weeks, 12 weeks and 24 weeks | No | |
Secondary | Body tone | 4 weeks, 12 weeks, 24 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |